Radiation Therapy and Concurrent Cisplatin in Management of Locoregionally Advanced Nasopharyngeal Carcinomas

References

• Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5 037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int .1-Radiat Oncol Biol Phys 1992; 23: 261–70.
   PubMed Web of Science ®Google Scholar
• Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affect-ing prognosis. Int .1- Radiat Oncol Biol Phys 1992; 23: 271–80.
   PubMed Web of Science ®Google Scholar
• Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int .1- Radiat Oncol Biol Phys 1997; 37: 985–96.
   PubMed Web of Science ®Google Scholar
• Sham JST, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990; 63: 51–8.
   PubMed Web of Science ®Google Scholar
• Al-Kourainy K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sar-raf M. Excellent response to cis-platinum-based chemother-apy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma. Am J Clin Oncol 1988; 11: 427–30.
   Google Scholar
• Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Hersekovic A, Ager PJ. Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1990; 8: 1342–51.
   Google Scholar
• Atichartakarn V, Kraiphibul P, Clongsusuek P, Pochanugool L. Kulapaditharom B, Ratanatharathorn V. Nasopharyngeal carcinoma: result of treatment with cis-diamminedichloroplat-inum II, 5-fluorouracil and radiation therapy. Int .1- Radiat Oncol Biol Phys 1988; 14: 461–9.
   PubMed Web of Science ®Google Scholar
• Clark JR, Norris CM, Dreyfuss AI, et al. Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radio-therapy. Ann Otol Rhinol Laryngol 1987; 96: 608–13.
   PubMedGoogle Scholar
• Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 1987; 5: 629–34.
   Google Scholar
• Lee AW, Chan DK, Fowler JF, et al. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 1995; 36: 24–31.
   PubMedGoogle Scholar
• Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991; 20: 823–33.
   PubMed Web of Science ®Google Scholar
• Wang CC. Radiation therapy for head and neck neoplasms. 3rd ed., New York: Wiley-Liss, Inc., 1997.
   Google Scholar
• Rossi A, Molinari R, Boracchi P, Vecchio MD, Marubini E, Nava M. Adjuvant chemotherapy with vincristine, cyclophos-phamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter ran-domized study. J Clin Oncol 1988; 6: 1401–10.
   PubMed Web of Science ®Google Scholar
• Bachouchi M, Cvitkovic E, Azli N, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy. J Natl Cancer Inst 1990; 82: 616–20.
   PubMedGoogle Scholar
• Dimery IW, Peters LJ, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in ad-vanced nasopharyngeal carcinoma. J Clin Oncol 1993; 11: 1919–28.
   PubMed Web of Science ®Google Scholar
• Chan AT, Teo PM, Leung TW, et al. A prospective random-ized study of chemotherapy adjunctive to definitive radiother-apy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995; 33: 569–77.
   PubMedGoogle Scholar
• Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radio-therapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 1998; 83: 2270–83.
   PubMed Web of Science ®Google Scholar
• International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radio-therapy vs. radiotherapy alone in stage IV ( N2, MO) undif-ferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996; 35: 463–9.
   Google Scholar
• Souhami L, Rabinowits M. Combined treatment in car-cinoma of the nasopharynx. Laryngoscope 1988; 98: 881–3.
   PubMed Web of Science ®Google Scholar
• Turner SL, Tiver KW. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 27: 371–7.
   PubMed Web of Science ®Google Scholar
• Dewit L. Combined treatment of radiation and cis-di-amminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987; 13: 403–26.
   PubMed Web of Science ®Google Scholar
• Forastiere AA. Cisplatin and radiotherapy in the manage-ment of locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1993; 27: 465–70.
   PubMedGoogle Scholar
• Forastiere AA. Concurrent cisplatinum and radiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1995; 31: 679–80.
   PubMedGoogle Scholar
• Fu KK, Phillips TL. Biological rationale of combined radio-therapy and chemotherapy. Hematol Oncol Clin North Am 1991; 5: 725–36.
   PubMedGoogle Scholar
• Al-Sarraf M, LeBlanc M, Gin i PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16: 1310–7.
   Google Scholar
• Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal car-cinoma. Cancer 1998; 82: 1003–12.
   PubMed Web of Science ®Google Scholar
• Choi KN, Rotman M, Aziz H, et al. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally ad-vanced nasopharyngeal and paranasal sinus tumors. Int J Radiat Oncol Biol Phys 1997; 39: 823–9.
   PubMedGoogle Scholar
• Lin JC, Chen KY, Jan JS, Hsu CY. Partially hyperfraction-ated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1996; 36: 1127–36.
   PubMed Web of Science ®Google Scholar
• Cheng SH, Jian JJ, Tsai SY, et al. Prognostic features and treatment outcome in locoregionally advanced nasopharyn-geal carcinoma following concurrent chemotherapy and ra-diotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 755–62.
   PubMed Web of Science ®Google Scholar